MedTrace Logo

Near Infrared Spectroscopy (St02)

NCT01062685 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 186

Last updated 2024-10-29

No results posted yet for this study

Summary

The overall hypotheses of this project is that Near Infrared Spectroscopy (NIRS) can be used to identify morbidity, mortality, and resource utilization in patients with sepsis and septic shock.

Conditions

  • Septic Shock

Interventions

DIAGNOSTIC_TEST

Near-infrared spectroscopy assessment

The InSpectra StO2 Tissue Oxygenation Monitor (model 650; Hutchinson Technology, Hutchinson, MN, USA) with probes spaced at 15 mm will be utilized to obtain StO2 measurements. Following a minimum initial five-minute stabilization period, the initial StO2 will be measurement and then a Vasoocclusive Testing Procedure (VOT) will be performed using an automated tourniquet (Delfi Tourniquet System; Delfi Medical Innovations, Inc, Vancouver, BC, Canada), insufflated to 50 mmHg over the patient's SBP for a period of three minutes.

Sponsors & Collaborators

  • Hutchinson Technology Inc

    collaborator INDUSTRY

  • Astute Medical, Inc.

    collaborator INDUSTRY

  • Axis Shield Diagnostics Ltd

    collaborator INDUSTRY

  • Beth Israel Deaconess Medical Center

    lead OTHER

Principal Investigators

  • Nathan I Shapiro, MD, MPH · Beth Israel Deaconess Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2010-01-31
Completion
2010-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01062685 on ClinicalTrials.gov